Xilio Therapeutics, Inc. (XLO)
SEC filings, insider trading & institutional ownership from EDGAR.
Couldn’t find the data you were looking for?
We haven’t added Xilio Therapeutics, Inc.’s filings yet. We add companies and filings all the time.
Track XLO and we’ll email you the moment its filings are in, free and with no account. Or create a free account to request coverage.
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G • latest quarter
| Holder | Filed | Value |
|---|---|---|
| Vanguard Capital Management | Aug 13, 2026 | $1.71M |
| RENAISSANCE TECHNOLOGIES LLC | Aug 13, 2026 | $614.6K |
| MORGAN STANLEY | Aug 13, 2026 | $545.6K |
| GEODE CAPITAL MANAGEMENT, LLC | Nov 6, 2026 | $375.1K |
| FMR LLC | May 15, 2026 | $307.5K |
XLO's filings are public. The insight is one click away.
Scrutar's AI reads every XLO filing and points out what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Never miss a XLO filing.
Get an email when XLO files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Nov 8, 2026Source: SEC EDGAR.